Source: Eur Respir Monogr 2015; 68: 186-201
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Adam Januszewski, Sanjay Popat. Chemotherapy. Eur Respir Monogr 2015; 68: 186-201

Member's Comments

No comment yet.

Related content which might interest you: Radiotherapy Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Effectiveness of oral metronomic Vinorelbine versus Docetaxel as second-line treatment in Non-Small Cell Lung Cancer patients in real life Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Pulmonary toxicity during chemotherapy with etopiside and carboplatin Source: Eur Respir J 2003; 22: Suppl. 45, 64s Year: 2003 Combination of oral and parenteral vinorelbine with cisplatin or carboplatin in adjuvant chemotherapy of nonsmall cell lung cancer - SWITCH study Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Resistance to chemotherapy in lung cancer Source: International Congress 2015 – Resistance to therapy in lung cancer Year: 2015 Consolidation maintenance oral vinorelbine following concurrent chemoradiation of intravenous vinorelbine and cisplatin in patients with unresectable stage III non-small cell lung cancer Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Immunotherapy Source: Eur Respir Monogr 2015; 68: 247-260 Year: 2015 Pulmonary function changes after chemotherapy and radiotherapy for Lymphoma. Source: International Congress 2017 – Case reports and series Year: 2017 Accelereated hyperfractionated radiotherapy with uneven crushing daily dose in chemoradiation treatment of inoperable non-small cell lung cancer Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Anticancer chemotherapy combined with anti-tuberculosis treatment: A systematic review Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Non-small cell lung cancer treatment: chemotherapy combination gemcitabine – cisplatin – paclitaxel Source: Eur Respir J 2004; 24: Suppl. 48, 302s Year: 2004 Tuberculosis therapy Source: International Congress 2016 – Historical landmarks in respiratory medicine: contributions from the UK Year: 2016 Role of chemotherapy and radiation therapy Source: Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment Year: 2012 Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015